arsenic and nrf2 signaling in cancer and diabetes | uab counteract
Published 2 years ago • 630 plays • Length 40:51Download video MP4
Download video MP3
Similar videos
-
54:53
chemical warfare exposures: focus on arsenical toxicity | uab counteract seminar
-
1:32
understanding the role of nrft2 signaling in hepatitis infections and liver cancer
-
1:43
the erα-nrf2 signaling axis promotes bicalutamide resistance in prostate cancer
-
1:05
i study how arsenic causes cancer - cristina andrade-feraud
-
0:15
is arsenic safe to use as a leukemia treatment?
-
1:38
nesfatin-3 has divalent metal ion affinities that are distinct from its precursor protein nucb2
-
1:26
the protein shp2 is a therapeutic target for diabetic nephropathy
-
10:45
ern genturis schwannomatosis guidelines
-
55:55
arsenic exposure and cardiovascular disease: what is the evidence in u.s. populations?
-
14:30
the detection of ntrk gene fusions in nsclc
-
21:30
virological approach - small interfering rna’s | stephen locarnini, bsc(hons), phd, mbbs, frc(path)
-
2:12
acrf incite centre
-
2:00
dr. goldberg on sequencing following treatment with osimertinib in nsclc
-
3:24
arise cancer consortium™
-
1:32
artacus: exploring the rp1 oncolytic virus for the treatment of cancer patients with cscc
-
1:44
codelivery of nrf 2 sirna and cyclophosphamide inhibits leukemia progression
-
6:09
significantly improving hrql and neurocognition in high-risk sickle cell following familial asct
-
52:07
hnrca scientific research clusters
-
3:32
acc 22: apollo fih study to investigate sirna in raised lipoprotein(a) | dr steven e nissen